MCID: LYM006
MIFTS: 45

Lymphoepithelioma-Like Carcinoma

Categories: Cancer diseases, Immune diseases

Aliases & Classifications for Lymphoepithelioma-Like Carcinoma

MalaCards integrated aliases for Lymphoepithelioma-Like Carcinoma:

Name: Lymphoepithelioma-Like Carcinoma 12 15
Lymphoepithelial Carcinoma 12 74
Nasopharyngeal Type Undifferentiated Carcinoma 12

Classifications:



External Ids:

Disease Ontology 12 DOID:5660
NCIt 51 C4107
SNOMED-CT 69 7300000
UMLS 74 C0334254

Summaries for Lymphoepithelioma-Like Carcinoma

Disease Ontology : 12 A carcinoma that is a malignant epithelial neoplasm densely infiltrated by lymphoid cells.

MalaCards based summary : Lymphoepithelioma-Like Carcinoma, also known as lymphoepithelial carcinoma, is related to lymphoepithelioma-like thymic carcinoma and sinonasal undifferentiated carcinoma. An important gene associated with Lymphoepithelioma-Like Carcinoma is KRT7 (Keratin 7), and among its related pathways/superpathways are Keratinization and Cytoskeletal Signaling. The drugs Cisplatin and Fluorouracil have been mentioned in the context of this disorder. Affiliated tissues include lung, breast and skin, and related phenotypes are Decreased shRNA abundance (Z-score < -2) and Decreased shRNA abundance (Z-score < -2)

Wikipedia : 77 Lymphoepithelioma-like carcinoma (LELC) is a medical term referring to a histological variant of... more...

Related Diseases for Lymphoepithelioma-Like Carcinoma

Diseases related to Lymphoepithelioma-Like Carcinoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 298)
# Related Disease Score Top Affiliating Genes
1 lymphoepithelioma-like thymic carcinoma 32.8 CD274 KRT18 KRT5
2 sinonasal undifferentiated carcinoma 30.7 ENO2 MUC1
3 eyelid carcinoma 30.5 KRT20 KRT7
4 basal cell carcinoma 30.4 KRT20 KRT7 KRT8
5 papilloma 30.2 KRT20 KRT5 KRT7 KRT8
6 epstein-barr virus-associated gastric carcinoma 30.2 CD274 CDH1
7 intrahepatic cholangiocarcinoma 29.9 CDH1 KRT20 KRT7 MUC1
8 adenosquamous carcinoma 29.8 KRT5 KRT7 KRT8 MUC1
9 papillary carcinoma 29.7 CDH1 KRT20 KRT7 MUC1
10 cholangiocarcinoma 29.2 CDH1 KRT18 KRT20 KRT7 KRT8 MUC1
11 lung cancer 28.8 CD274 CDH1 ENO2 KRT18 KRT20 KRT7
12 infiltrating bladder lymphoepithelioma-like carcinoma 12.5
13 cervical lymphoepithelioma-like carcinoma 12.5
14 lymphoma 10.5
15 pulmonary hemosiderosis 10.4 KRT7 MUC1
16 adenomyoma 10.4 KRT7 MUC1
17 sertoli-leydig cell tumor 10.4 KRT7 MUC1
18 spindle cell sarcoma 10.4 KRT7 MUC1
19 sclerosing hemangioma 10.4 KRT7 MUC1
20 monophasic synovial sarcoma 10.4 KRT7 MUC1
21 brachydactyly, type e1 10.4 KRT20 MUC1
22 gastrointestinal carcinoma 10.4 KRT20 MUC1
23 well-differentiated liposarcoma 10.4 KRT7 MUC1
24 jejunal adenocarcinoma 10.4 KRT20 KRT7
25 endocervical adenocarcinoma 10.4 KRT20 KRT7
26 bladder lymphoma 10.4 KRT20 KRT7
27 chronic cystitis 10.4 KRT20 KRT7
28 rectum adenocarcinoma 10.4 KRT20 KRT7
29 vulva adenocarcinoma 10.4 KRT20 KRT7
30 papillary serous adenocarcinoma 10.4 KRT20 KRT7
31 dendritic cell tumor 10.4 KRT20 MUC1
32 prostatic acinar adenocarcinoma 10.4 KRT20 KRT7
33 cecum adenocarcinoma 10.4 KRT20 KRT7
34 inverted papilloma 10.4 KRT20 KRT7
35 ovarian mucinous adenocarcinoma 10.4 KRT20 KRT7
36 bladder adenocarcinoma 10.4 KRT20 KRT7
37 medulloepithelioma 10.4 KRT20 KRT7
38 renal pelvis carcinoma 10.4 KRT20 KRT7
39 thymus adenocarcinoma 10.4 KRT20 KRT7
40 adenocarcinoma in situ 10.4 KRT20 KRT7
41 ovarian cystic teratoma 10.4 KRT20 KRT7
42 glycogen-rich clear cell breast carcinoma 10.4 KRT20 KRT7
43 appendix disease 10.4 KRT20 KRT7
44 ovarian mucinous neoplasm 10.4 KRT20 KRT7
45 squamous cell papilloma 10.4
46 meibomian cyst 10.4 KRT20 KRT7
47 clear cell adenocarcinoma 10.4 KRT20 KRT7
48 anal canal adenocarcinoma 10.4 CD274 KRT7
49 pilomatrixoma 10.4 ENO2 MUC1
50 optic nerve glioma 10.4 ENO2 MUC1

Graphical network of the top 20 diseases related to Lymphoepithelioma-Like Carcinoma:



Diseases related to Lymphoepithelioma-Like Carcinoma

Symptoms & Phenotypes for Lymphoepithelioma-Like Carcinoma

GenomeRNAi Phenotypes related to Lymphoepithelioma-Like Carcinoma according to GeneCards Suite gene sharing:

27 (show all 12)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased shRNA abundance (Z-score < -2) GR00366-A-153 9.58 KRT5
2 Decreased shRNA abundance (Z-score < -2) GR00366-A-154 9.58 KRT18
3 Decreased shRNA abundance (Z-score < -2) GR00366-A-17 9.58 KRT18 KRT5
4 Decreased shRNA abundance (Z-score < -2) GR00366-A-180 9.58 KRT5 KRT8
5 Decreased shRNA abundance (Z-score < -2) GR00366-A-200 9.58 KRT5
6 Decreased shRNA abundance (Z-score < -2) GR00366-A-33 9.58 KRT18
7 Decreased shRNA abundance (Z-score < -2) GR00366-A-40 9.58 KRT8
8 Decreased shRNA abundance (Z-score < -2) GR00366-A-68 9.58 KRT7
9 Decreased shRNA abundance (Z-score < -2) GR00366-A-71 9.58 KRT18 KRT5 KRT7 KRT8
10 Decreased shRNA abundance (Z-score < -2) GR00366-A-72 9.58 KRT7
11 Decreased shRNA abundance (Z-score < -2) GR00366-A-84 9.58 KRT18
12 Decreased shRNA abundance (Z-score < -2) GR00366-A-91 9.58 KRT5 KRT7

Drugs & Therapeutics for Lymphoepithelioma-Like Carcinoma

Drugs for Lymphoepithelioma-Like Carcinoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 185)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cisplatin Approved Phase 3,Phase 2,Phase 1 15663-27-1 2767 441203 84093
2
Fluorouracil Approved Phase 3,Phase 2,Phase 1 51-21-8 3385
3
Gemcitabine Approved Phase 2, Phase 3,Phase 1 95058-81-4 60750
4
Carboplatin Approved Phase 2, Phase 3,Phase 1 41575-94-4 10339178 38904 498142
5
Paclitaxel Approved, Vet_approved Phase 2, Phase 3,Phase 3,Phase 1 33069-62-4 36314
6
Docetaxel Approved, Investigational Phase 3,Phase 2,Phase 1 114977-28-5 148124
7
Amifostine Approved, Investigational Phase 3,Phase 2 20537-88-6 2141
8
Histamine Approved, Investigational Phase 3 51-45-6 774
9
Doxepin Approved, Investigational Phase 3 1668-19-5 667468 667477
10
Diphenhydramine Approved, Investigational Phase 3 147-24-0, 58-73-1 3100
11
Promethazine Approved, Investigational Phase 3 60-87-7 4927
12
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
13
Fluconazole Approved, Investigational Phase 2, Phase 3 86386-73-4 3365
14
Miconazole Approved, Investigational, Vet_approved Phase 2, Phase 3,Phase 1 22916-47-8 4189
15
Cevimeline Approved Phase 3 107233-08-9 25137844 83898
16
Megestrol acetate Approved, Investigational, Vet_approved Phase 3 595-33-5 11683
17
Cobalt Approved, Experimental Phase 3 7440-48-4 104729
18
Lenograstim Approved, Investigational Phase 3,Phase 2,Phase 1 135968-09-1
19 Pancreatic Polypeptide Investigational Phase 3 59763-91-6
20 Porfiromycin Investigational Phase 3 801-52-5
21 Antimetabolites Phase 3,Phase 2,Phase 1
22 Antimetabolites, Antineoplastic Phase 3,Phase 2,Phase 1
23 Immunosuppressive Agents Phase 3,Phase 2,Phase 1
24 Immunologic Factors Phase 3,Phase 2,Phase 1,Not Applicable
25 Neurotransmitter Agents Phase 3,Phase 2,Not Applicable
26 Analgesics Phase 3,Phase 2
27 Liver Extracts Phase 3,Phase 2,Phase 1
28 Peripheral Nervous System Agents Phase 3,Phase 2,Not Applicable
29 Cola Phase 3,Phase 2,Phase 1,Not Applicable
30 Nucleic Acid Synthesis Inhibitors Phase 3,Phase 2,Phase 1
31 Antibiotics, Antitubercular Phase 3,Phase 2,Phase 1
32 Anti-Bacterial Agents Phase 3,Phase 2,Phase 1
33 Cytochrome P-450 Enzyme Inhibitors Phase 2, Phase 3
34 Anti-Infective Agents Phase 2, Phase 3,Phase 3,Phase 1
35 Autonomic Agents Phase 3,Phase 2,Not Applicable
36 Antineoplastic Agents, Phytogenic Phase 2, Phase 3,Phase 3,Phase 1
37 Albumin-Bound Paclitaxel Phase 2, Phase 3,Phase 3,Phase 1
38 Antimitotic Agents Phase 2, Phase 3,Phase 3,Phase 1
39 Antiviral Agents Phase 2, Phase 3,Phase 1
40 Protective Agents Phase 3,Phase 2
41 Radiation-Protective Agents Phase 3,Phase 2
42 Histamine Antagonists Phase 3
43 Psychotropic Drugs Phase 3
44 Central Nervous System Depressants Phase 3
45 Antidepressive Agents, Tricyclic Phase 3
46 Antidepressive Agents Phase 3
47
Histamine Phosphate Phase 3 51-74-1 65513
48 Hypnotics and Sedatives Phase 3
49 Narcotics Phase 3
50 Adjuvants, Anesthesia Phase 3

Interventional clinical trials:

(show top 50) (show all 93)
# Name Status NCT ID Phase Drugs
1 Radiation Therapy Alone Compared to Radiation Therapy Plus Chemotherapy in Treating Patients With Previously Untreated Cancer of the Nasopharynx Unknown status NCT00003637 Phase 3 cisplatin;fluorouracil
2 Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer Completed NCT00274937 Phase 3 amifostine trihydrate;fluorouracil;cisplatin
3 Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy Completed NCT01156142 Phase 3 doxepin hydrochloride
4 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
5 Acupuncture or Standard Therapy in Treating Pain and Dysfunction in Patients Who Have Undergone Neck Surgery for Head and Neck Cancer Completed NCT00090337 Phase 3
6 Radiation Therapy and Chemotherapy in Treating Patients With Head and Neck Cancer Completed NCT00002507 Phase 3 mitomycin C;porfiromycin
7 Fluconazole in Preventing Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer Completed NCT00002533 Phase 2, Phase 3 fluconazole
8 Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer Completed NCT00017511 Phase 3 cevimeline hydrochloride
9 Megestrol to Limit Weight Loss and Improve Quality of Life in Treating Patients With Head and Neck Cancer Completed NCT00006799 Phase 3 megestrol acetate
10 Study of Nutrition Regimens in Treating Patients With Cancer of the Upper Aerodigestive Tract Completed NCT00765440 Phase 3
11 Fractionated Radiation Therapy in Treating Advanced Squamous Cell Carcinoma of the Head and Neck Completed NCT00771641 Phase 3
12 Cisplatin and RT With or Without Gemcitabine, Carboplatin, and Paclitaxel in Treating Patients With Locally Advanced NPC Active, not recruiting NCT00997906 Phase 2, Phase 3 carboplatin,;cisplatin;gemcitabine hydrochloride;paclitaxel
13 Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery Terminated NCT00113399 Phase 3 cisplatin;docetaxel;fluorouracil;paclitaxel
14 Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery Withdrawn NCT00041171 Phase 3 Hypericum perforatum;docetaxel
15 Gemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic or Locally Recurrent Epstein-Barr Virus-Positive Nasopharyngeal Cancer Unknown status NCT00690872 Phase 2 carboplatin;gemcitabine hydrochloride
16 Vaccine Therapy and Celecoxib in Treating Patients With Metastatic Nasopharyngeal Cancer Unknown status NCT00589186 Phase 2 celecoxib
17 Fluorouracil, Cisplatin, and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Nasopharyngeal Cancer Unknown status NCT00093665 Phase 2 cisplatin;fluorouracil
18 Docetaxel and S-1 Followed By Radiation Therapy and Low-Dose Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer Unknown status NCT00625937 Phase 2 cisplatin;docetaxel;tegafur-gimeracil-oteracil potassium
19 Cisplatin-Epinephrine Injectable Gel Plus Paclitaxel and Carboplatin in Treating Patients With Recurrent Head and Neck Cancer Unknown status NCT00022217 Phase 2 carboplatin;cisplatin-e therapeutic implant;paclitaxel
20 External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases Unknown status NCT00637637 Phase 2 indinavir sulfate;ritonavir
21 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or Larynx Unknown status NCT00004094 Phase 2 carboplatin;fluorouracil;hydroxyurea;paclitaxel
22 Cetuximab (ERBITUX®) Added to Two Concurrent Chemoradiotherapy Platforms in Locally Advanced Head and Neck Cancer Unknown status NCT00468169 Phase 2 Cetuximab
23 Phenylbutyrate and Valganciclovir in Treating Patients With Relapsed or Refractory Epstein-Barr Virus-Positive Cancer Unknown status NCT00387530 Phase 2 oral sodium phenylbutyrate;valganciclovir
24 Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck Completed NCT00084318 Phase 2 cisplatin;docetaxel
25 Imatinib Mesylate in Treating Patients With Salivary Gland Cancer Completed NCT00045669 Phase 2 imatinib mesylate
26 Pazopanib Hydrochloride in Treating Patients With Stage IV or Recurrent Nasopharyngeal Cancer Completed NCT00454142 Phase 2 pazopanib hydrochloride
27 Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy Completed NCT02123511 Phase 2 acetylcysteine
28 Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer Completed NCT00492089 Phase 2 bevacizumab;placebo
29 Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer Completed NCT00101348 Phase 1, Phase 2 erlotinib hydrochloride
30 High-Dose Radiation Therapy Plus Chemotherapy in Treating Patients With Advanced Nose or Throat Cancer Completed NCT00052429 Phase 1, Phase 2 cisplatin;fluorouracil
31 Chemotherapy in Treating Patients With Solid Tumors Completed NCT00003103 Phase 1, Phase 2 docetaxel
32 High-dose ICE With Amifostine Completed NCT00003657 Phase 2 Amifostine;Carboplatin;Etoposide;Ifosfamide
33 Docetaxel in Treating Patients With Solid Tumors Completed NCT00003565 Phase 2 docetaxel
34 Oxaliplatin and Capecitabine in Treating Patients With Relapsed or Metastatic Head and Neck Cancer Completed NCT00448552 Phase 2 capecitabine;oxaliplatin
35 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Mouth Cancer Completed NCT00004901 Phase 1, Phase 2 ethynyluracil;fluorouracil;hydroxyurea
36 Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor Completed NCT00021047 Phase 1, Phase 2 capecitabine;carboplatin;epirubicin hydrochloride
37 Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors Completed NCT00019331 Phase 2 DetoxPC
38 Gemcitabine and Doxorubicin in Treating Patients With Recurrent or Progressive Head and Neck Cancer Completed NCT00509665 Phase 2 doxorubicin hydrochloride;gemcitabine hydrochloride
39 Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung Cancer Completed NCT00021333 Phase 2 cisplatin;paclitaxel
40 Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer Completed NCT00002515 Phase 2 carboplatin;thiotepa;topotecan hydrochloride
41 Cabozantinib in Combination With Nivolumab and Ipilimumab in Rare Genitourinary Tumors Recruiting NCT03866382 Phase 2 Cabozantinib;Cabozantinib S-malate
42 Phase 2 Sequential and Concurrent Chemoradiation for Advanced Nasopharyngeal Carcinoma (NPC) Active, not recruiting NCT00896181 Phase 2 docetaxel;cisplatin;carboplatin;fluorouracil
43 18F FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy Active, not recruiting NCT01806675 Phase 1, Phase 2 fludeoxyglucose F 18;2-fluoropropionyl-labeled pegylated dimeric RGD peptide
44 Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer Completed NCT00470496 Phase 1 HPPH;photodynamic therapy
45 Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer Completed NCT01637194 Phase 1 everolimus
46 Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors Completed NCT00089362 Phase 1 alvespimycin hydrochloride
47 Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer Completed NCT00023959 Phase 1 hydroxyurea;fluorouracil
48 Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer Completed NCT00397384 Phase 1 cetuximab;erlotinib hydrochloride
49 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) Completed NCT00031681 Phase 1 7-hydroxystaurosporine;irinotecan hydrochloride
50 Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction Completed NCT00030498 Phase 1 erlotinib hydrochloride

Search NIH Clinical Center for Lymphoepithelioma-Like Carcinoma

Genetic Tests for Lymphoepithelioma-Like Carcinoma

Anatomical Context for Lymphoepithelioma-Like Carcinoma

MalaCards organs/tissues related to Lymphoepithelioma-Like Carcinoma:

42
Lung, Breast, Skin, Cervix, Salivary Gland, Liver, Brain

Publications for Lymphoepithelioma-Like Carcinoma

Articles related to Lymphoepithelioma-Like Carcinoma:

(show top 50) (show all 428)
# Title Authors Year
1
Lymphoepithelioma-like carcinoma of the skin: a possible culprit when biopsy indicates a benign inflammatory reaction. ( 30229889 )
2019
2
Lymphoepithelioma-Like Carcinoma of the Uterine Cervix: A Pathologic Study of Eight Cases With Emphasis on the Association With Human Papillomavirus. ( 30321260 )
2019
3
Epstein-Barr Virus-Associated Pulmonary Carcinoma: Proposing an Alternative Term and Expanding the Histologic Spectrum of Lymphoepithelioma-like Carcinoma of the Lung. ( 30334830 )
2019
4
Prognostic Value and Clinical Impact of Pretreatment FDG PET in Pulmonary Lymphoepithelioma-Like Carcinoma. ( 30608914 )
2019
5
Primary pulmonary lymphoepithelioma-like carcinoma combined with situs inversus totalis. ( 30614861 )
2019
6
Pulmonary Lymphoepithelioma-like Carcinoma. ( 30672338 )
2019
7
Lymphoepithelioma-like carcinoma of breast: A case report and review of the literature. ( 30706876 )
2019
8
Tracheal Lymphoepithelioma-Like Carcinoma on FDG PET/CT. ( 31021917 )
2019
9
Lymphoepithelial carcinoma of the accessory parotid gland. ( 30928150 )
2019
10
Synchronous hepatocellular carcinoma and lymphoepithelioma-like carcinoma arising from 2 different sites of the liver: A case report. ( 30290612 )
2018
11
Inflammatory Stroma of Lymphoepithelioma-like Carcinoma of the Cervix: Immunohistochemical Study of 3 Cases and Review of the Literature. ( 28985196 )
2018
12
Clinical Significance of Plasma Epstein-Barr Virus DNA in Pulmonary Lymphoepithelioma-like Carcinoma (LELC) Patients. ( 29191777 )
2018
13
Lymphoepithelioma-like carcinoma of the uterine cervix: Cytomorphologic features and diagnostic pitfalls by liquid-based cytology. ( 29218797 )
2018
14
Lymphoepithelioma-like carcinoma of the large intestine: A case report and literature review. ( 29290316 )
2018
15
Prognosis and distribution of lymph nodes metastases in resectable primary pulmonary lymphoepithelioma-like carcinoma: A large cohort from a single center. ( 29327422 )
2018
16
Primary pulmonary lymphoepithelioma-like carcinoma in Singapore. ( 29387253 )
2018
17
Primary pulmonary lymphoepithelioma-like carcinoma in non-endemic region: A case report and literature review. ( 29465599 )
2018
18
About a case of lymphoepithelioma-like carcinoma of the bladder. ( 29556475 )
2018
19
Pulmonary Lymphoepithelioma-like Carcinoma Disguised as Squamous Cell Carcinoma. ( 29703540 )
2018
20
Correlation and prognostic significance of PD-L1 and P53 expression in resected primary pulmonary lymphoepithelioma-like carcinoma. ( 29707344 )
2018
21
Lung cavity accompanied by hemoptysis: lymphoepithelioma-like carcinoma. ( 29722879 )
2018
22
Lymphoepithelioma-like carcinoma of the skin. ( 29723365 )
2018
23
PIK3CA and p53 Mutations by Next Generation Sequencing in Lymphoepithelioma-Like Carcinoma of the Endometrium. ( 29854528 )
2018
24
Lymphoepithelioma-like carcinoma of the endometrium: Case report of a rare tumour with comprehensive immunohistochemical and molecular analysis. ( 29895132 )
2018
25
Expression of PD-L1/PD-1 in lymphoepithelioma-like carcinoma of the thymus. ( 29973653 )
2018
26
Lymphoepithelioma-Like Carcinoma of the Bladder: A Case Report of a Rare and Particular Variant of Urothelial Carcinoma. ( 30073111 )
2018
27
Lymphoepithelioma-Like Carcinoma of the Breast: A Case Report Unveiling Several Clinical and Histopathological Challenges. ( 30123609 )
2018
28
A rare pure lymphoepithelioma-like carcinoma of the renal pelvis mimicking upper tract urothelial carcinoma: A potential diagnostic pitfall. ( 30392573 )
2018
29
About a lymphoepithelioma-like carcinoma of the lung with an endotracheal localization. ( 30430492 )
2018
30
EBV-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma Response to PD-L1 Blockade. ( 30679078 )
2018
31
Clinical Features and Prognosis of Pulmonary Lymphoepithelioma-like Carcinoma: Summary of Eighty-five Cases. ( 30683631 )
2018
32
Lymphoepithelial carcinoma in parotid gland related to EBV infection: A case report. ( 28139343 )
2018
33
A rare case of esophageal lymphoepithelial carcinoma without Epstein-Barr virus infection. ( 29183763 )
2018
34
Diagnosis of lymphoepithelial carcinoma in parotid gland with three dimensional computed tomography angiography reconstruction: A case report. ( 29480238 )
2018
35
Lymphoepithelial carcinoma of the maxillary sinus: A case report and review of the literature. ( 29995775 )
2018
36
Human papillomavirus in laryngeal and hypopharyngeal lymphoepithelial carcinoma. ( 30552415 )
2018
37
Coexistence of Lymphoepithelial Carcinoma of the Parotid Gland and Submandibular Gland Pleomorphic Adenoma. ( 28570397 )
2017
38
Collision of Lymphoepithelioma-like Carcinoma with Diffuse Large B-cell Lymphoma of the Stomach: A Case Report. ( 28739754 )
2017
39
Lymphoepithelioma-Like Carcinoma of the Breast Mimicking Granulomatous Mastitis- Case Report and Review of the Literature ( 28749097 )
2017
40
Cytological features of lymphoepithelioma-like carcinoma of the breast. ( 27478161 )
2017
41
18F-FDG PET/CT of common hepatic duct lymphoepithelioma-like carcinoma. ( 27836588 )
2017
42
Lymphoepithelioma-Like Carcinoma of the Skin-A Rare Tumor Treated by Slow Mohs Micrographic Surgery. ( 27846013 )
2017
43
Dermoscopic Features of Cutaneous Lymphoepithelioma-Like Carcinoma. ( 27930377 )
2017
44
Advanced primary pulmonary lymphoepithelioma-like carcinoma: clinical manifestations, treatment, and outcome. ( 28203414 )
2017
45
Lymphoepithelioma-like carcinoma of cervix: Cytological Features on Conventional Cervical Smear. ( 28211234 )
2017
46
Lymphoepithelioma-like carcinoma of the uterine cervix. ( 28217683 )
2017
47
Primary Pulmonary Lymphoepithelioma-like Carcinoma on FDG PET/CT. ( 28250863 )
2017
48
Lymphoepithelioma-like carcinoma of the ureter: a rare presentation, synchronous with conventional urothelial carcinoma. ( 28263136 )
2017
49
Lymphoepithelioma-like carcinoma of the upper urinary tract. ( 28455741 )
2017
50
Lymphoepithelioma-Like Carcinoma in Liver. ( 28500863 )
2017

Variations for Lymphoepithelioma-Like Carcinoma

Expression for Lymphoepithelioma-Like Carcinoma

Search GEO for disease gene expression data for Lymphoepithelioma-Like Carcinoma.

Pathways for Lymphoepithelioma-Like Carcinoma

Pathways related to Lymphoepithelioma-Like Carcinoma according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Show member pathways
11.81 KRT18 KRT20 KRT5 KRT7 KRT8
2 11.66 CDH1 KRT18 KRT20 KRT5 KRT7 KRT8
3 11.6 CD274 CDH1 PDCD1
4
Show member pathways
11.49 KRT18 KRT5 KRT7 KRT8

GO Terms for Lymphoepithelioma-Like Carcinoma

Cellular components related to Lymphoepithelioma-Like Carcinoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular exosome GO:0070062 9.76 CD274 CDH1 ENO2 KRT18 KRT5 KRT7
2 keratin filament GO:0045095 9.26 KRT18 KRT5 KRT7 KRT8
3 intermediate filament GO:0005882 9.02 KRT18 KRT20 KRT5 KRT7 KRT8

Biological processes related to Lymphoepithelioma-Like Carcinoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 keratinization GO:0031424 9.35 KRT18 KRT20 KRT5 KRT7 KRT8
2 hepatocyte apoptotic process GO:0097284 9.16 KRT18 KRT8
3 cornification GO:0070268 9.02 KRT18 KRT20 KRT5 KRT7 KRT8

Molecular functions related to Lymphoepithelioma-Like Carcinoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 protein binding GO:0005515 9.65 CD274 CDH1 ENO2 KRT18 KRT20 KRT5
2 structural molecule activity GO:0005198 8.85 KRT18
3 scaffold protein binding GO:0097110 8.8 KRT18 KRT5 KRT8

Sources for Lymphoepithelioma-Like Carcinoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....